AI
Wednesday, July 31, 2019 11:05:24 AM
Thanks for posting Jefra.
Yep, we CVSI is definitely undervalued, so I would expect we have room to grow, and once NASDAQ is approved, this stock will take off, catch up to CW or surpass it. But it may very well do that without the NAS as well!
I saw this article yesterday, but noted that chart #7 located just under #4. Attractive Valuation market share was off; from last reports CW had 12.9% of market and CV had 12.6% of market. Then I noticed the footnotes, these are results from a survey, not from actual sales, so the demographics used in this survey should be considered.
Footnotes:
Figure 7 | Responses to question: "Which is your preferred CBD brand?" (Only hemp-derived CBD brands represented in graphic)
Have a great day!
Yep, we CVSI is definitely undervalued, so I would expect we have room to grow, and once NASDAQ is approved, this stock will take off, catch up to CW or surpass it. But it may very well do that without the NAS as well!
I saw this article yesterday, but noted that chart #7 located just under #4. Attractive Valuation market share was off; from last reports CW had 12.9% of market and CV had 12.6% of market. Then I noticed the footnotes, these are results from a survey, not from actual sales, so the demographics used in this survey should be considered.
Footnotes:
Figure 7 | Responses to question: "Which is your preferred CBD brand?" (Only hemp-derived CBD brands represented in graphic)
Have a great day!
